标题 |
16 Primary Results From the Randomized Phase II RIGHT Choice Trial of Premenopausal Patients With Aggressive HR+/HER2- Advanced Breast Cancer Treated With Ribociclib + Endocrine Therapy vs Physician's Choice Combination Chemotherapy
16在绝经前侵袭性HR+/HER2-晚期乳腺癌患者中采用Ribociclib+内分泌治疗与医师选择联合化疗的随机II期RIGHT Choice试验的主要结果
|
网址 | |
DOI |
暂未提供,该求助的时间将会延长,查看原因?
|
求助人 | |
下载 |